A Phase II, Multicenter, Double Blind, Placebo-Controlled Safety, Tolerability Study of BMS-708163 in Patients With Mild to Moderate Alzheimer's Disease

NCT00810147 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

209

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer's Disease

Interventions

DRUG: BMS-708163
DRUG: BMS-708163
DRUG: BMS-708163
DRUG: BMS-708163
DRUG: Placebo

Sponsor

Bristol-Myers Squibb